Subscribe to RSS
Ovine Biosynthetic Grafts for Aortoiliac Reconstructions in Nonsterile Operative Fields
Background Prosthetic vascular grafts placed surgically or via endovascular techniques can be subject to the risk of life-threatening graft infections. The Omniflow II vascular prosthesis is a biosynthetic graft that was reported to have favorable properties in resisting infections.
Materials and Methods We retrospectively reviewed our 3 years' experience of using the Omniflow II prostheses for aortoiliac reconstructions in patients considered to carry a substantial risk of subsequent prosthetic graft infections (prevention group) as well as in patients with actively infected prosthetic vascular grafts (treatment group).
Results Aorto-bi-iliac (n = 4) and aortobifemoral (n = 12) vascular reconstructions were performed using bifurcated Omniflow II prostheses in nine patients in the prevention group and seven patients in the treatment group. During mean follow-up of 28.6 ± 17.2 months, there was one case of graft infection (6.3%) and graft thrombosis (6.3%) with subsequent successful thrombectomy. Early and late surgical revisions were required in eight (50%) and two (12.6%) patients, respectively. All graft prostheses were patent at last follow-up.
Conclusion Using bifurcated Omniflow II vascular prostheses in patients with or at a high risk of vascular graft infection is advisable, and is associated with acceptable reinfection and patency rates.
Received: 14 October 2020
Accepted: 14 December 2020
Article published online:
04 February 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Lyons OTA, Baguneid M, Barwick TD. et al. Diagnosis of aortic graft infection: a case definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg 2016; 52 (06) 758-763
- 2 Shiraev T, Barrett S, Heywood S. et al. Incidence, management and outcomes of aortic graft infection. Ann Vasc Surg 2019; 59: 73-83
- 3 Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008; 47 (02) 264-269
- 4 Post ICJH, Vos CG. Systematic review and meta-analysis on the management of open abdominal aortic graft infections. Eur J Vasc Endovasc Surg 2019; 58 (02) 258-281
- 5 O'Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 2006; 44 (01) 38-45
- 6 Chakfé N, Diener H, Lejay A. et al; ESVS Guidelines Committee. Editor's choice - European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of vascular graft and endograft infections. Eur J Vasc Endovasc Surg 2020; 59 (03) 339-384
- 7 van Zitteren M, van der Steenhoven TJ, Burger DH, van Berge Henegouwen DP, Heyligers JM, Vriens PW. Spiral vein reconstruction of the infected abdominal aorta using the greater saphenous vein: preliminary results of the Tilburg experience. Eur J Vasc Endovasc Surg 2011; 41 (05) 637-646
- 8 Dorweiler B, Neufang A, Chaban R, Reinstadler J, Duenschede F, Vahl CF. Use and durability of femoral vein for autologous reconstruction with infection of the aortoiliofemoral axis. J Vasc Surg 2014; 59 (03) 675-683
- 9 Harlander-Locke MP, Harmon LK, Lawrence PF. et al; Vascular Low-Frequency Disease Consortium. The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. J Vasc Surg 2014; 59 (03) 669-674
- 10 Batt M, Jean-Baptiste E, O'Connor S. et al. In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. Eur J Vasc Endovasc Surg 2008; 36 (02) 182-188
- 11 Krasznai AG, Snoeijs M, Siroen MP. et al. Treatment of aortic graft infection by in situ reconstruction with Omniflow II biosynthetic prosthesis. Vascular 2016; 24 (06) 561-566
- 12 Betz T, Neuwerth D, Steinbauer M, Uhl C, Pfister K, Töpel I. Biosynthetic vascular graft: a valuable alternative to traditional replacement materials for treatment of prosthetic aortic graft infection?. Scand J Surg 2019; 108 (04) 291-296
- 13 Töpel I, Uhl C, Ayx I, Steinbauer M. Xenografts in septic vascular surgery. Gefasschirurgie 2016; 21 (Suppl. 02) 55-58
- 14 Stather PW, Howard AQ. A novel technique for bifurcated bovine plus Omniflow aortic graft reconstruction. Eur J Vasc Endovasc Surg 2017; 53 (01) 104
- 15 Neufang A, Dorweiler B, Espinola-Klein C. et al. Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J Vasc Surg 2014; 60 (06) 1543-1553
- 16 Dünschede F, Stabrauskaite J, Weisser G, Espinola-Klein C, Dorweiler B, Vahl CF. Crural bypass for critical lower limb ischemia with Omniflow II prosthesis. Thorac Cardiovasc Surg 2016; 64 (04) 311-315
- 17 Neufang A, Duenschede F, Espinola-Klein C. et al. Contemporary results with the biosynthetic glutaraldehyde denatured ovine collagen graft (Omniflow II) in femoropopliteal position. J Vasc Surg 2020; 71 (05) 1630-1643
- 18 Dünschede F, Youssef M, Stabrauskaite J. et al. Omniflow-II™ for critical limb ischemia: long-term results [in German]. Chirurg 2017; 88 (03) 233-238
- 19 Edwards GA, Roberts G. Development of an ovine collagen-based composite biosynthetic vascular prosthesis. Clin Mater 1992; 9 (3-4): 211-223
- 20 Omniflow® II Biosynthetic Vascular Prosthesis. Product Information. . LeMaitre Vascular. Accessed date: 1 September 2020 at: https://www.lemaitre.com/products/omniflow-ii-biosynthetic-vascular-prosthesis
- 21 Inston NG. Long-term results of biological grafts for haemodialysis vascular access. J Vasc Access 2015; 16 (09) 82-86
- 22 De Siqueira JR, Sun ZDY, Tahir W, Bhasin N, Parry D. Use of Omniflow® II in infected vascular grafts with femoral anastomotic dehiscence. Ann Vasc Surg 2020; 65: 160-165
- 23 Batt M, Feugier P, Camou F. et al; Research Group for Vascular Graft Infection. A meta-analysis of outcomes after in situ reconstructions for aortic graft infection. Angiology 2018; 69 (05) 370-379
- 24 Töpel I, Stigler T, Ayx I, Betz T, Uhl C, Steinbauer M. Biosynthetic grafts to replace infected prosthetic vascular bypasses: a single-center experience. Surg Infect (Larchmt) 2017; 18 (02) 202-205